Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
CDK8/19i maintains pluripotency of mouse PSCs in culture
primarily as a preventative to reduce the frequency of recurrent migraine headaches
InChi: InChI=1S/C27H43N3O4
but it is now rarely employed because of its higher incidence of severe adverse effects
AC710 - CAS# 1351522-04-7 aempferol CDK8/19i maintains pluripotency of mouseAC710 is a potent, orally active, and selective platelet derived growth factor receptor family kinase inhibitor with potential anticancer activity. Its IC50 values are 1. 2, 2, 7. 7 and 10. 5 nM for KIT, FLT3, PDGFR and CSF1R respectively; Kd = 1. 3 nM for PDGFR.. AC710 causes tumor regression of leukemia cell xenografts in mice. AC710 also reduces joint swelling and inflammation in a mouse model of collagen induced arthritis. AC710 is now a
US$ 20280.00
US$ 8347.50
US$ 8347.50
US$ 27300.00
US$ 18375.00
US$ 8919.75
US$ 6474.00
US$ 9423.75
US$ 7586.25
US$ 8347.50